PSCC Connect
Connecting the people and organisations shaping innovation in oncology
Joining PSCC Connect means becoming part of a community of + 200 organisations dedicated to advancing innovation in oncology. Through exchange of insights, networking and long-term support, PSCC Connect fosters collaboration and helps accelerate innovation in the fight against cancer, for the benefit of patients.
The association's colleges
Grandes entreprises
Bristol-Myers Squibb GSK Servier Ipsen Johnson & Johnson Merck Sanofi Takeda Représentants au Conseil d'administration : Christian Deleuze (Sanofi) Nathalie Depreville (Servier) Catherine George (Ipsen) Philippe Jacquot (Takeda)
PME
Abbelight Abcely Adlin Science AI4bio Algenscribe Altevax Apmonia Therapeutics Aqemia Ardan Pharma ASQII Biocytex Blue Bees Therapeutics Brenus Pharma Celeos Cherry Biotech Cure51 Cyberna Cytea bio Emglev Therapeutics e-miRgency ErVimmune EverImmune Exosome Analytics Fasten Genexpath Gliocure GMT Science Hephaïstos pharma Hippoxis Imaginostics, Inc. Infocus Innate Pharma IntegraGen IterOnco Mabqi Magic Genomix McSAF Mnemo Therapeutics MPC Therapeutics MSInsight Neolys-Diagnostics NeoVentures Biotechnology Europe Newteam Medical NK Diagnostics Occlugel Odimma-Therapeutics Okomera On/Off Therapeutics Oncodesign Precision Medicine Onconex Remunity Therapeutics One Biosciences Orakl Oncology Oranomed Orinova Owkin OWL Lifesciences Pegascy Pepkon Persea Proimaging Promontory Therapeutics Proskope Prostperia Qalita Quniten Health Robeauté Rosetta Omics See2cure Serendip innovations SmartCatch Sur'Touch Telomium Theranovir Theraonco Therapanacea Therasonic Yomi Représentants au Conseil d'administration : Stéphanie Cornen (Innate Pharma) Nathalie Donne (Ervimmune) Quentin Lubart (Abbelight) Wahid Awad (Rosetta Omics)
ETI Institutions
Calym CCI du Val-de-Marne Etablissement Public d'Aménagement Paris Saclay France Biotech Grand-Orly Seine Bièvre Institut Polytechnique de Paris Matwin Medicen Paris Region Paris Est Marne et Bois Fondation PSCC Wilco Représentants au Conseil d'administration : Etienne Lonchamp (Medicen) Lucia Robert (Matwin)
Entreprises support à la recherche
ACROBiosystems Affinisep Agile Capital Markets Agilent Technologies Alhena Consult Alter Ego biotech Antineo Ariana Pharma AxiomHealth Capital Innovation B2G Life Sciences Berthelot DDC Biodeigma Biogael consulting Biognosys Biophact Bio-Techne Biotem Capital Cell Cell'Ectiv CKD Pharma Consulting CliniSciences Diverchim Dlog consulting ERBC Group Explicyte Fidal Firalis Molecular Precision GxP Quality Services HMC Matching Hologic diagenode Icosa ILife Consulting Illumina Inferential Inits JCBioconsultEU JPT Peptide Technologies Kadans Keyrus KYomed Innov Lab2Biotech Lavoix Leads To Development Lipomize Maxcyte Merck Life Sciences Mission Bio Myriagone Conseil New England Biolabs Novaxia Nuvisan Oncodesign services Oncofactory Parean Biotechnologies Pearl Biosystem Phinc PL-Conseil Promega France Qualees RD-Biotech Seqalis Simbec-Orion skepsos Sphere Bio Stilla Technologies Tebubio SAS Therawings consulting Thermo Fisher Scientific ULTRace Development Partner Voxcan XenTech Représentants au Conseil d'administration : Tanja Ouimet (ILife Consulting) Amaury Lachaud (Biognosys)
Investisseurs
Andera Partners Angels Santé Bioqube Ventures Bpifrance G Ventures JEITO Capital Sofinnova Partners Technofounders Représentants au Conseil d'Administration : Julien Elric (Jeito) Stéphane Loze (Angel Santé)
Discover the association
PSCC Connect is a non-profit association established under the French Law of 1901, bringing together organisations from across the Paris-Saclay Cancer Cluster ecosystem to advance oncology innovation. Its ambition is to connect organisations with complementary expertise, foster new collaborations and support the development of innovative solutions that benefit patients.
More than a professional network, PSCC Connect is an active community of start-ups, SMEs, mid-sized and large companies, investors, research support companies, institutions and innovation partners. It provides ongoing support to its members and encourages collaboration across the ecosystem.
By joining the association, members can stay at the forefront of developments in oncology, expand their networks, share their expertise and contribute to shaping the future of cancer care.
The association works to:
Represent
The members of the ecosystem and ensure their needs and priorities are heard.
Accelerate
The development of innovative projects.
Promote
Collaboration across the ecosystem and create new opportunities for its
members.
Engage
The community through events, networking opportunities and thematic working
groups.
All organisations wishing to contribute to innovation in the fight against cancer are welcome to join PSCC Connect.
Our achievements
PSCC Connect addresses the ecosystem’s needs through working groups and events bringing together between 10 and over 700 participants.
These initiatives focus on two complementary areas: addressing unmet medical needs (pancreatic cancer, glioblastoma, gastrointestinal stromal tumours (GIST), paediatric cancers and more) and exploring the technologies transforming oncology (AI, radiopharmaceuticals, proteomics, novel therapies, diagnostics, medical devices and more).
Our events
Investor Talks
Engage directly with investors to gain insights into their investment strategies, selection criteria and expectations.
Exclusive to PSCC Connect “Start-ups & SMEs” college
Masterclasses & Workshops
Explore scientific topics and development challenges in depth with experts, and discuss their practical implications.
Exclusive to members of the PSCC Connect “Mid-sized & Large companies”, “Start-ups & SMEs” and “investors” colleges, and BOOST start-ups
Oncology Industry Meeting
Foster connections between start-ups and pharmaceutical companies through panel discussions, one-to-one meetings and dedicated networking opportunities.
Exclusive to members of the PSCC Connect “Mid-sized & Large companies” college, and BOOST start-ups
Investor Committees and Portfolio Reviews
Get expert insights and strategic feedback on development plans and funding prospects of your project.
Exclusive to members of the PSCC Connect “Mid-sized & Large companies” and “investors” colleges, and BOOST start-ups
Coffee Break Connect
Connect with fellow members who share a professional field or area of interest during informal 90-minute sessions designed to encourage meaningful conversations and new connections.
Exclusive to PSCC Connect members
Ecosystem Breakfasts
Discover the expertise, services and capabilities of organisations across the ecosystem at fortnightly breakfast sessions, with opportunities to meet their
teams and exchange ideas.
Open to all
PSCC Thursdays
Explore the multiple perspectives from scientific, industry and investment partners on key issues in oncology through discussions and networking opportunities, approximately every six weeks.
Open to all
Lunch & Learn
Engage directly with an academic expert in a small-group setting to explore scientific or strategic topics related to oncology innovation.
Open to all
Scientific Symposia
Learn from experts in complementary disciplines to explore scientific topics such
as glioblastoma, artificial intelligence and immuno-oncology, digital twins in
healthcare, and therapeutic peptides.
Open to all
PSCC Innovation Forum
Join more than 700 stakeholders from across the ecosystem for conferences, panel discussions and B2B meetings. This event provides a platform to share the latest advances and forge new collaborations.
Open to all
Webinars
Share knowledge, expertise and practical insights remotely on scientific and professional topics shaping the oncology sector.
Open to all
Our working groups
To address the needs of the PSCC Connect community, working groups bring
together complementary expertise to explore shared challenges, exchange
knowledge and foster new collaborations.
Examples of topics and initiatives include:
Therapeutic peptides,
Pancreatic cancer,
Glioblastoma,
OMIDAS (Link to the Nature publication),
Diagnostics.
+ 200
members
"Join PSCC Connect now and help build what will become a unique community, entirely dedicated to innovation in oncology, whatever the technology. By combining our strengths and dreams, our talents and expertise, doing our best to collaborate and bringing all our energy to bear, we will accelerate innovation in the fight against cancer, for the benefit of patients."
Christian Deleuze, PSCC Connect President
.jpg)
PSCC Summer Summit
AI4 Clinical Trial Symposium
Digital Twin Symposium
WorkShop Glioblastoma
.jpg)
Industry Meeting
Why become a member?
Your community at your fingertips
Through the PSCC Connect app, connect with over 200 organisations working to advance oncology innovation. Expand your network, share opportunities and stay up to date with the latest developments across the ecosystem.
Share knowledge and expertise
Broaden your knowledge through scientific and professional events across the ecosystem. Access exclusive member events and resources, including summaries, presentations, event recordings and insights from PSCC Connect working groups.
Help shape a collaborative community
Suggest new topics, join or initiate working groups, and share your expertise to help shape future PSCC Connect initiatives.
Opportunities tailored to your organisation
>
Start-ups and SMEs
-
Exchange insights and experiences with peers on project development and funding.
-
Identify potential scientific and industry partners.
-
Join or initiate thematic working groups.
-
Take part in Investor Talks and Masterclasses.
>
Large Companies and Investors
-
Discover innovative oncology projects.
-
Connect with start-ups and key opinion leaders to explore potential
collaborations. -
Participate in portfolio reviews and tailored events.
>
Research Support Companies
-
Showcase your expertise and capabilities.
-
Connect with potential partners.
-
Present at Ecosystem Breakfasts.
The 5 Colleges of PSCC Connect
The association's colleges
Représentants au Conseil d'administration :
Claude Bertrand
vice-président exécutif R&D du groupe Servier et gérant de l'Institut de Recherches Internationales Servier
Titulaire
